<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">892</journal-id><journal-id journal-id-type="pmc-domain">vetres</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6858679</article-id><article-id pub-id-type="pmcid-ver">PMC6858679.1</article-id><article-id pub-id-type="pmcaid">6858679</article-id><article-id pub-id-type="pmcaiid">6858679</article-id><article-id pub-id-type="pmid">31730501</article-id><article-id pub-id-type="doi">10.1186/s13567-019-0714-3</article-id><article-id pub-id-type="publisher-id">714</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Rev1 <italic toggle="yes">wbdR</italic> tagged vaccines against <italic toggle="yes">Brucella ovis</italic></article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names initials="B">Beatriz</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>de Miguel</surname><given-names initials="MJ">Mar&#237;a Jes&#250;s</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mart&#237;nez-G&#243;mez</surname><given-names initials="E">Estrella</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names initials="A">Amaia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salvador-Besc&#243;s</surname><given-names initials="M">Miriam</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names initials="I">Ignacio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iriarte</surname><given-names initials="M">Maite</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names initials="PM">Pilar M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0046-3577</contrib-id><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names initials="R">Raquel</given-names></name><address><email>rconde@unav.es</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419370271</institution-id><institution-id institution-id-type="GRID">grid.5924.a</institution-id><institution>Instituto de Salud Tropical (ISTUN), Instituto de Investigaci&#243;n Sanitaria de Navarra (IdiSNA) and Dpto. de Microbiolog&#237;a y Parasitolog&#237;a, </institution><institution>Universidad de Navarra, </institution></institution-wrap>c/Irunlarrea 1, 31008 Pamplona, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2152 8769</institution-id><institution-id institution-id-type="GRID">grid.11205.37</institution-id><institution>Unidad de Producci&#243;n y Sanidad Animal, Instituto Agroalimentario de Arag&#243;n-IA2 (CITA-Universidad de Zaragoza), </institution></institution-wrap>Av. Monta&#241;ana 930, 50059 Saragossa, Spain </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="ppub"><year>2019</year></pub-date><volume>50</volume><issue-id pub-id-type="pmc-issue-id">327125</issue-id><elocation-id>95</elocation-id><history><date date-type="received"><day>5</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>11</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>29</day><month>11</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-20 23:25:14.580"><day>20</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13567_2019_Article_714.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" xlink:title="correction" vol="51" journal-id="Vet Res" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC7029569"><article-title>Correction to: Rev1 <italic>wbdR</italic> tagged vaccines against <italic>Brucella ovis</italic></article-title><volume>51</volume><date><day>19</day><month>2</month><year>2020</year></date><elocation-id>13</elocation-id><source>Veterinary Research</source><pub-id pub-id-type="pmcid">PMC7029569</pub-id><pub-id pub-id-type="pmid">32070427</pub-id></related-article><abstract id="Abs1"><p id="Par1">Sheep brucellosis is a worldwide extended disease caused by <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic>, two species respectively carrying smooth or rough lipopolysaccharide. Vaccine <italic toggle="yes">B. melitensis</italic> Rev1 is used against <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> but induces an anti-smooth-lipopolysaccharide response interfering with <italic toggle="yes">B. melitensis</italic> serodiagnosis, which precludes its use against <italic toggle="yes">B. ovis</italic> where <italic toggle="yes">B. melitensis</italic> is absent. In mice, Rev1 deleted in <italic toggle="yes">wbkC</italic> (<italic toggle="yes">Brucella</italic> lipopolysaccharide formyl-transferase) and carrying <italic toggle="yes">wbdR</italic> (<italic toggle="yes">E. coli</italic> acetyl-transferase) triggered antibodies that could be differentiated from those evoked by wild-type strains, was comparatively attenuated and protected against <italic toggle="yes">B. ovis</italic>, suggesting its potential as a <italic toggle="yes">B. ovis</italic> vaccine.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Econom&#237;a y Competitividad</institution></institution-wrap></funding-source><award-id>BES-2015-075609</award-id><award-id>AGL-2014-58795-C4-1-R</award-id><principal-award-recipient><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names>Beatriz</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>ISTUN FUNDERS</institution></funding-source><award-id>Obra Social la CAIXA, &#8220;Fundaciones Caja Navarra&#8221; and &#8220;Roviralta, PROFAND, Ubesol, ACUNSA&#8221;</award-id><award-id>&#8220;Artai&#8221;</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Brucellosis is one of the most common zoonoses worldwide, causing significant loss to animal production and severely affecting human health [<xref ref-type="bibr" rid="CR1">1</xref>]. The etiological agents of brucellosis are Gram-negative bacteria of the genus <italic toggle="yes">Brucella.</italic> This genus includes several zoonotic species among which <italic toggle="yes">B. abortus</italic> preferentially infects cattle, <italic toggle="yes">B.</italic>&#160;<italic toggle="yes">suis</italic> swine and wild-life and <italic toggle="yes">B. melitensis</italic> goats and sheep [<xref ref-type="bibr" rid="CR2">2</xref>]. Sheep can also be infected by <italic toggle="yes">B. ovis</italic>, a non-zoonotic species [<xref ref-type="bibr" rid="CR2">2</xref>]. These species are smooth (S) or rough (R), depending on the presence or absence respectively of O-polysaccharide (O-PS) chains in the outer membrane lipopolysaccharide (LPS). Whereas <italic toggle="yes">B. abortus</italic>, <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. suis</italic> carry a S-LPS, <italic toggle="yes">B. ovis</italic> is a naturally a&#160;R species [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par3"><italic toggle="yes">B. ovis</italic> infection causes genital lesions and reduced fertility constituting one of the most important causes of reproductive failure in sheep [<xref ref-type="bibr" rid="CR3">3</xref>]. Animal vaccination is the most suitable method for controlling brucellosis in areas with moderate to high prevalence of the disease. Currently, no specific vaccines against <italic toggle="yes">B. ovis</italic> infection are available, but the S live attenuated <italic toggle="yes">B. melitensis</italic> Rev1 vaccine, widely used for vaccination against ovine and caprine brucellosis caused by <italic toggle="yes">B. melitensis</italic>, is also effective against <italic toggle="yes">B. ovis</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. However, Rev1 is virulent in humans, induces abortions when used in pregnant animals [<xref ref-type="bibr" rid="CR4">4</xref>] and is resistant to streptomycin, an antibiotic of choice for brucellosis treatment [<xref ref-type="bibr" rid="CR5">5</xref>]. While these problems can be solved by using appropriate vaccination strategies and biosafety precautions [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], Rev1 also induces a strong antibody response to the O-PS section of S-LPS [<xref ref-type="bibr" rid="CR7">7</xref>] thus hampering differentiation between true infected and vaccinated animals (DIVA problem) in the routine diagnosis of <italic toggle="yes">B. melitensis</italic>. Because of this, Rev1 is banned in the countries where <italic toggle="yes">B. melitensis</italic> has been eradicated, resulting in a subsequent increase in <italic toggle="yes">B. ovis</italic> infections in sheep. Since <italic toggle="yes">B. ovis</italic> is naturally R, some attempts to circumvent the problems associated with Rev1 vaccination in <italic toggle="yes">B. melitensis</italic>-free areas have been based on the use of <italic toggle="yes">B. ovis</italic>. Accordingly, some investigations have examined subcellular vaccines carrying <italic toggle="yes">B. ovis</italic> fractions rich in envelope components in lipid-muramyl dipeptide or nanoparticle adjuvants [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. However, these formulations either provide less protection than Rev1 or become too costly. Also, <italic toggle="yes">B. ovis</italic> mutants in LPS core genes [<xref ref-type="bibr" rid="CR10">10</xref>] have been explored with promising results. Similarly, a mutant in putative ABC transporter encapsulated in alginate has been proposed as <italic toggle="yes">B. ovis</italic> vaccine [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Yet, industrial production of these vaccines would require solving the problem posed by <italic toggle="yes">B. ovis</italic> CO<sub>2</sub>-dependence [<xref ref-type="bibr" rid="CR13">13</xref>] with the subsequent reassessment of their properties. Moreover the ABC transporter mutant requires encapsulation [<xref ref-type="bibr" rid="CR12">12</xref>]. R mutants of S <italic toggle="yes">Brucella</italic> species (i.e., the so-called R vaccines) are more easily produced and, as they lack the O-PS, are often assumed to solve the Rev1 DIVA problem. However, R vaccines still interfere in S-LPS ELISA [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>] because of the cross-reactivity with the core epitopes shared by the S and R-LPS or, in the <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> and related <italic toggle="yes">B. melitensis</italic> 115 spontaneous R mutants, presence of a cytoplasm O-PS precursor [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>]. Another approach was to delete protein BP26. However, whereas the BP26-deleted Rev1 provides protection against <italic toggle="yes">B. ovis</italic>, the ancillary BP26 ELISA lacks adequate diagnostic sensitivity [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. More recently, a Rev1 construct expressing the green fluorescent protein as a tagging antigen has been proposed. However, this method requires the simultaneous injection of this protein and a booster injection to trigger antibody persisting in the ancillary ELISA&#8208;green fluorescent protein DIVA test [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par4">The aim of this research is to investigate an alternative to circumvent the serological diagnosis problems caused by the Rev1 vaccine while keeping its good attenuation and protection characteristics. Our approach differs from those summarized above in that, instead of deleting S <italic toggle="yes">Brucella</italic> antigens or epitopes or introducing a foreign antigen, we have modified a <italic toggle="yes">Brucella</italic> immunodominant antigen. For this purpose, we applied to Rev1 the strategy proposed by Mart&#237;nez-G&#243;mez et al. [<xref ref-type="bibr" rid="CR23">23</xref>] to modify the epitopic structure of <italic toggle="yes">Brucella</italic> S-LPS by substituting the N-formyl-perosamine of the O-PS by N-acetyl-perosamine. We present here the experiments carried out in the mouse model as a first step to investigate the validity of this approach.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Bacterial strains and growth conditions</title><p id="Par5">The bacterial strains and plasmids used are listed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>. For construction of mutants, <italic toggle="yes">B. melitensis</italic> 16&#160;M and Rev1 strains were grown at 37&#160;&#176;C in tryptic soy broth (TSB, Biom&#233;rieux, Marcy l&#8217;Etoile, France) or in this medium supplemented with agar (TSA, Pronadisa, Conda, Spain). <italic toggle="yes">B. ovis</italic> strains were grown at 37&#160;&#176;C in TSB supplemented with 0.5% yeast extract (Pronadisa, Conda, Spain) and 5% fetal bovine serum (TYSB-S) or this medium supplemented with agar (TYSA-S). For the studies in mice, vaccines and challenge strain were grown in Blood Agar Base (BAB, Oxoid) or BAB-S (supplemented with 5% fetal bovine serum). Where needed, media were supplemented with 5% sucrose (Sigma), diaminopimelic acid (DAP; 1&#160;mM), 0.2% activated charcoal (Sigma), kanamycin (Km) at 50&#160;&#181;g/mL, chloramphenicol (Cm) at 20&#160;&#181;g/mL, ampicillin (Amp) at 100&#160;&#181;g/mL, polymyxin (Pmx) at 1.5&#160;&#181;g/mL or streptomycin (Strp) at 2.5&#160;&#181;g/mL. All strains were stored at &#8722;80&#160;&#176;C in skimmed milk (Scharlau, Barcelona, Spain) or TYSB-7% dimethylsulfoxide (DMSO).</p></sec><sec id="Sec4"><title>DNA manipulations</title><p id="Par6">Plasmid and chromosomal DNA were extracted with Q1Aprep<sup>&#174;</sup> spin Miniprep Kit (Qiagen GmbH, Hilden, Germany) and Ultraclean Microbial DNA Isolation Kit (Mo Bio Laboratories), respectively. When needed, DNA was purified from agarose gels using a QIAquick Gel extraction kit (Qiagen). DNA sequencing was performed by &#8220;Servicio de Secuenciaci&#243;n del Centro de Investigaci&#243;n M&#233;dica Aplicada&#8221; (Pamplona, Spain). Primers were synthesized by Sigma-Genosys Ltd. (Haverhill, United Kingdom).</p></sec><sec id="Sec5"><title>Construction of mutants</title><p id="Par7">For the construction of Rev1::Tn7<italic toggle="yes">wbdR</italic>Km<sup>R</sup> mutants, we used the plasmid pYRI-27 (pUC18R6KT-miniTn7T-Km-P<italic toggle="yes">wbdR</italic>) described in Mart&#237;nez-G&#243;mez et al. [<xref ref-type="bibr" rid="CR23">23</xref>]. The acquisition of this vector by <italic toggle="yes">Brucella</italic> after tetra-parental mating with conjugative <italic toggle="yes">E. coli</italic> S17.1 &#955;pir and <italic toggle="yes">E. coli</italic> HB101 (pRK2013) and <italic toggle="yes">E. coli</italic> SM10 &#955;pir (pTNS2) was selected by Km and Pmx resistance. The correct insertion and orientation of the miniTn7 carrying <italic toggle="yes">wbdR</italic> was examined by PCR as previously described [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par8">To obtain a <italic toggle="yes">wbdR</italic> construct with no Km resistance (Rev1::Tn7<italic toggle="yes">wbdR</italic>), we used the plasmid pRCI-65 (pNPTS138Cm<sup>R</sup>&#916;<italic toggle="yes">Km</italic>) described in Mart&#237;nez-G&#243;mez et al. [<xref ref-type="bibr" rid="CR23">23</xref>]. This suicide plasmid containing the <italic toggle="yes">Km</italic>R deletion allele was transformed into <italic toggle="yes">E. coli</italic> &#946;2150, a diaminopimelic acid (DAP) auxotrophic donor strain, to avoid the use of antibiotic during the conjugation process [<xref ref-type="bibr" rid="CR24">24</xref>] and transferred into Rev1::Tn7<italic toggle="yes">wbdR</italic>Km<sup>R</sup> by conjugation. The integration of the suicide vector and disruption of the target gene were selected by Km sensitivity and confirmed by PCR using oligonucleotides <italic toggle="yes">KmR</italic>-F1 and <italic toggle="yes">KmR</italic>-R4 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>).</p><p id="Par9">Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> was constructed in a similar way. The suicide plasmid pYRI-31 (pJQKm&#916;<italic toggle="yes">wbkC</italic>) [<xref ref-type="bibr" rid="CR23">23</xref>] was used to delete the <italic toggle="yes">wbkC</italic> gene of Rev1::Tn7<italic toggle="yes">wbdR</italic> by allelic change. The resulting mutator plasmid was introduced in Rev1::Tn7<italic toggle="yes">wbdR</italic> by conjugation using the <italic toggle="yes">E. coli</italic> &#946;2150. The loss of the plasmid concomitant with the deletion of <italic toggle="yes">wbkC</italic> gene was checked by PCR using oligonucleotides <italic toggle="yes">wbkC</italic>-F1 and <italic toggle="yes">wbkC</italic>-R4 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>).</p><p id="Par10">The strain <italic toggle="yes">B. ovis</italic> PA-KmR, used as challenge in mouse experiments (see below), was obtained using the modified miniTn7 site-specific integration vector technology [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec6"><title>Characterization of the mutants</title><p id="Par11">Mutants were characterized by the standard <italic toggle="yes">Brucella</italic> typing procedures described in Alton et al. [<xref ref-type="bibr" rid="CR27">27</xref>]: colonial morphology, urease, susceptibility to thionine blue, fuchsine and safranine, acriflavine agglutination, crystal violet dye exclusion test (S/R colony morphology), agglutination with anti-A and anti-M monospecific sera, and sensitivity to phages. For co-agglutination, bacteria resuspended in 25 &#181;L of saline on a glass slide were mixed with an equal amount staphylococci sensitized with anti-Formyl-Acetyl, anti-Acetyl and anti-Formyl sera, as previously described [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec7"><title>LPS extraction</title><p id="Par12">LPS from Rev1 and Rev1 <italic toggle="yes">wbdR</italic> tagged was obtained by the proteinase-K sodium dodecyl sulfate (SDS) protocol [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] with some modifications. Briefly, cells inactivated with phenol were suspended in 2% SDS-60&#160;mM Tris&#8211;HCl buffer (pH 6.8), heated at 100&#160;&#176;C for 10&#160;min and treated with proteinase K (60 &#181;L of a 2.5&#160;mg/mL stock per each mL of suspension, 3&#160;h at 55&#160;&#176;C). This was followed by two consecutive precipitations with 3 volumes of methanol with 1% sodium acetate-saturated methanol at &#8722;20&#160;&#176;C. After centrifugation, pellets were resuspended by sonication in 3&#160;mL of 60&#160;mM HCl-Tris (pH 6.8), digested with nucleases and treated again with proteinase K (3&#160;h at 55&#160;&#176;C). After a third precipitation, the pellet containing LPS was recovered in 1&#160;mL of distilled water and frozen.</p></sec><sec id="Sec8"><title>SDS-PAGE and Western blots</title><p id="Par13">Samples were mixed 1:1 with Sample buffer 2x (Bio-Rad), heated at 100&#160;&#176;C for 10&#160;min, and analyzed in 15% polyacrylamide gels in Tris&#8211;HCl-glycine and stained by the periodate-alkaline silver method [<xref ref-type="bibr" rid="CR30">30</xref>]. For Western blots, LPS were analyzed in SDS-PAGE gel (12% polyacrylamide) (see above) and electrotransferred onto nitrocellulose blotting sheets (Amersham- GE Healthcare Life Scientific, Germany; 0.45&#160;&#181;m pore size). The polyclonal sera used were the following: Anti-S <italic toggle="yes">Brucella</italic> serum (polyclonal serum from a rabbit infected with <italic toggle="yes">B. melitensis</italic> 16&#160;M and bled at day 45), Formyl-Acetyl serum and Acetyl serum. These last two sera were obtained by the method described in Mart&#237;nez-G&#243;mez et al. [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec9"><title>Multiplex PCR</title><p id="Par14">To discriminate between Rev1 <italic toggle="yes">wbdR</italic> tagged strains and all known <italic toggle="yes">Brucella</italic> species and vaccine strains, we designed a pair of primers based on the <italic toggle="yes">wbdR</italic> gene and added them to the 8 pairs of primers used in the Bruce-ladder assay [<xref ref-type="bibr" rid="CR31">31</xref>]. These new primers consisted of 5&#180;-TGATGTTTTGGCAGGAAAGA-3&#8242; (<italic toggle="yes">wbdR</italic> forward) and 5&#8242;-TAGCCCCAGGAGCAAATGTA-3&#8242; (<italic toggle="yes">wbdR</italic> reverse). We designed them with a Tm similar to that of the other primers used in the multiplex PCR and amplifying a band of 347&#160;bp that did not prevent the visualization of the other specific bands of species or vaccine strains.</p></sec><sec id="Sec10"><title>Studies in mice: virulence and protection</title><p id="Par15">Seven-week-old female BALB/C mice (ENVIGO, Harlan) were kept in cages in BSL-3 facilities (ES/31-2010-000132) with water and food <italic toggle="yes">al libitum</italic>. Procedures were in accordance with the current European (directive 86/609/EEC) and Spanish (RD 53/2013) legislations, supervised by the corresponding Ethical Committee for Animal Experimentation and authorised by Arag&#243;n (reports No. 2014-20 and 2014-21) and Navarra (CEEA 045/12) Governments. For virulence assessment, 10-mice groups were inoculated intraperitoneally (IP) with 1&#8201;&#215;&#8201;10<sup>5</sup> or 1&#8201;&#215;&#8201;10<sup>8</sup> colony forming units (CFU) of the corresponding strain and mean CFU values per spleen were determined at 1 (<italic toggle="yes">n</italic>&#8201;=&#8201;5) and 5 (<italic toggle="yes">n</italic>&#8201;=&#8201;5) weeks after inoculation as described elsewhere [<xref ref-type="bibr" rid="CR32">32</xref>]. To evaluate the protective efficacy of Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> vaccine, 5-mice groups were vaccinated subcutaneously (SC) with two different doses (1&#8201;&#215;&#8201;10<sup>5</sup> and 1&#8201;&#215;&#8201;10<sup>8</sup> CFU/mouse). Mice (<italic toggle="yes">n</italic>&#8201;=&#8201;5) inoculated SC with the Rev1 reference vaccine (1&#8201;&#215;&#8201;10<sup><italic toggle="yes">5</italic></sup> CFU/mouse) or sterile Buffered Saline (BSS; 0.85% NaCl, 0.1% KH<sub>2</sub>PO<sub>4</sub>, 0.2% K<sub>2</sub>HPO<sub>4</sub>; pH 6.85) were used as effective-vaccine and unvaccinated controls, respectively. Four weeks after vaccination, mice were challenged IP with 5&#8201;&#215;&#8201;10<sup>6</sup> CFU/mouse of <italic toggle="yes">B. ovis</italic> PA-KmR and the mean CFU/spleen values of this strain were determined 2&#160;weeks after. Inocula were prepared by&#160;harvesting the BAB or BAB-S grown bacteria in sterile BSS, adjusting spectrophotometrically (600&#160;nm) the bacterial suspension and making proper serial tenfold dilutions. Mice were inoculated with 0.1&#160;mL and doses were retrospectively assessed by plating inocula countable dilutions. Differentiation between challenge and vaccine strains was achieved by plating on BAB supplemented with streptomycin and BAB-S supplemented with Km (incubated in CO<sub>2</sub> atmosphere). Results were expressed as the mean log<sub>10</sub> CFU/spleen&#8201;&#177;&#8201;SD (<italic toggle="yes">n</italic>&#8201;=&#8201;5) of the corresponding mutant or challenge strain and units of protection were calculated by subtracting the mean log<sub>10</sub> CFU values of the vaccine group from those of unvaccinated controls. Statistical comparisons were made by one-way ANOVA and Fisher&#8217;s Protected Least Significant Differences (PLSD) post hoc tests. The adequate virulence of <italic toggle="yes">B. ovis</italic> PA-KmR challenge strain was proved in a previous experiment in BALB/c mice by IP infection (5&#8201;&#215;&#8201;10<sup>5</sup> CFU/mouse) and bacterial spleen counting (in BAB-S and BAB-S supplemented with Km) 3 and 8&#160;weeks later. This strain showed identical multiplication to that of <italic toggle="yes">B. ovis</italic> PA (not shown).</p></sec><sec id="Sec11"><title>Enzyme-linked immunosorbent assay (iELISA)</title><p id="Par16">Serum antibodies of mice inoculated with Rev1 (parental strain), Rev1::Tn7<italic toggle="yes">wbdR</italic>, Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and <italic toggle="yes">B. melitensis</italic> 16&#160;M (as control) were analyzed using an iELISA with wild-type (N-formyl-perosamine) or modified (N-acetyl-perosamine) S-LPS as antigens. For this, 96-well plates (Thermo Scientific, Waltham, MA, USA) were coated by overnight incubation at 4&#160;&#176;C with <italic toggle="yes">B. melitensis</italic> 16&#160;M or Ba::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> S-LPS at 2.5&#160;&#181;g/mL or 5&#160;&#181;g/mL, respectively, in PBS. Plates were washed with PBS-0.05% Tween 20 (and incubated with serial dilutions of sera at 37&#160;&#176;C for 30&#160;min. After washing, antibodies were detected with peroxidase-labeled protein G [<xref ref-type="bibr" rid="CR19">19</xref>] and 2,2&#8242;-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS)-H<sub>2</sub>O<sub>2</sub>. After 15&#160;min, colorimetric reactions were read at 405&#160;nm (Multiescanex, Thermo Scientific, Waltman, MA, USA). Results are expressed as optical density (O.D.) values of tested sera after subtracting the O.D. value of the negative control (blank well) in the same plate.</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Insertion of <italic toggle="yes">wbdR</italic> into Rev1 genome modifies the epitopic structure of the vaccine</title><p id="Par17">To obtain a tagged Rev1 vaccine, we followed two strategies. First, we obtained Rev1::Tn7<italic toggle="yes">wbdR</italic> inserting <italic toggle="yes">wbdR</italic> in the chromosome II of Rev1 vaccine using the previously described Tn7 methodology [<xref ref-type="bibr" rid="CR8">8</xref>]. Second, we constructed a <italic toggle="yes">wbdR</italic> tagged Rev1 lacking N-formyl-perosamine in its O-PS (Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC)</italic> deleting <italic toggle="yes">wbkC</italic> (the formyl transferase gene) from Rev1::Tn7<italic toggle="yes">wbdR.</italic> As expected, these constructs could be differentiated from Rev1, vaccine <italic toggle="yes">B. abortus</italic> S19, or representative strains of wild-type <italic toggle="yes">B. abortus</italic>, <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> by PCR using the Multiplex-PCR combining Bruce-ladder and <italic toggle="yes">wbdR</italic> specific primers (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p><bold><italic toggle="yes">wbdR</italic></bold><bold> tagged vaccines can be identified by a modified multiplex PCR assay.</bold> Identification and differentiation of <italic toggle="yes">Brucella</italic> species, classical vaccines and Rev1 <italic toggle="yes">wbdR</italic> tagged vaccines by a modified Bruce-Ladder [<xref ref-type="bibr" rid="CR31">31</xref>] that includes a new pair of primers based on the <italic toggle="yes">wbdR</italic> gene that amplify a band of 347&#160;bp specific for tagged vaccines. C&#8211;(H<sub>2</sub>O) and PM (1&#160;Kb plus DNA ladder) used as molecular size marker.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13567_2019_714_Fig1_HTML.jpg"/></fig>
</p><p id="Par18">Rev1::Tn7<italic toggle="yes">wbdR</italic> and Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> were identical to the parental strain in colony morphology, growth, oxidase and urease tests and dye sensitivity (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Consistent with previous results in virulent <italic toggle="yes">B. melitensis</italic> 16&#160;M [<xref ref-type="bibr" rid="CR23">23</xref>], Rev1::Tn7<italic toggle="yes">wbdR</italic> and Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> did not agglutinate with acriflavine and excluded crystal violet, properties characteristic of strains expressing S-LPS. On the other hand, both <italic toggle="yes">wbdR</italic> tagged strains were sensitive to phage R/C, a phage specific for the O-PS-lacking R brucellae [<xref ref-type="bibr" rid="CR27">27</xref>], a phenotype not observed previously on <italic toggle="yes">wbdR</italic> constructs of virulent strains.</p><p id="Par19">The LPS extracts of Rev1::Tn7<italic toggle="yes">wbdR</italic> and Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> contained the typical R-LPS (i.e. low molecular weight) and S-LPS (higher molecular weight) fractions present in the parental strain (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>). However, as observed before for their <italic toggle="yes">wbdR</italic> tagged <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> and <italic toggle="yes">B. abortus</italic> counterparts [<xref ref-type="bibr" rid="CR23">23</xref>], the S-LPS fraction of the <italic toggle="yes">wbdR</italic> constructs displayed an apparent average molecular weight lower than those of the parental strains (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>A). To analyze possible epitopic changes associated with <italic toggle="yes">wbdR</italic> tagging, whole cells and LPS extracts were tested by co-agglutination and Western blot, respectively, using immune sera specifically recognizing O-PS carrying only N-formyl-perosamine (anti-Formyl), both N-formyl-perosamine and N-acetyl-perosamine (anti-Formyl-Acetyl) or only N-acetyl-perosamine (anti-Acetyl) [<xref ref-type="bibr" rid="CR23">23</xref>]. Rev1::Tn7<italic toggle="yes">wbdR</italic> co-agglutinated with staphylococci sensitized with anti-Formyl-Acetyl, anti-Acetyl and anti-Formyl sera showing that its O-PS contained N-acetyl and N-formyl-perosamine. In contrast, Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> did not co-agglutinate with anti-Formyl serum, while keeping the anti-Formyl-Acetyl and anti-Acetyl reactivity (Additional file <xref rid="MOESM4" ref-type="media">4</xref>). Western blots with proteinase-K extracted S-LPS (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>B) confirmed the epitopic changes and demonstrated that the differences in apparent average molecular weight observed by SDS-PAGE (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>A) corresponded in fact to O-PS heterogeneity.<fig id="Fig2" position="float" orientation="portrait"><label>Figure&#160;2</label><caption><p><bold>Insertion of</bold>
<bold><italic toggle="yes">wbdR</italic></bold><bold> into Rev1 genome modifies the epitopic structure of the vaccine.</bold>
<bold>A</bold> SDS-PAGE electrophoresis-silver staining and <bold>B</bold> Western blot analyses of SDS-proteinase K extracts of (1) Rev1, (2) Rev1::Tn7<italic toggle="yes">wbdR,</italic> and (3) Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13567_2019_714_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec14"><title><italic toggle="yes">wbdR</italic> tagging decreases the residual virulence of Rev1</title><p id="Par20">We vaccinated BALB/c mice with 10<sup>5</sup> CFU/mouse (standard dose for <italic toggle="yes">Brucella</italic> S vaccines) of Rev1::Tn7<italic toggle="yes">wbdR</italic>, Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and Rev1 and determined CFU numbers in spleen. One week post-infection, CFU/spleen values were significantly lower in mice infected with Rev1::Tn7<italic toggle="yes">wbdR</italic> or Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> than in those infected with Rev1 (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). At week 5, though both Rev1::Tn7<italic toggle="yes">wbdR</italic> and Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> also showed lower CFU, only the values of Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> were statistically different (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). However, attenuation with respect to Rev1 was clearly observed for both tagged vaccines at post-infection weeks 1 and 5 when the experiment was carried out with 10<sup>8</sup> CFU/mouse, the dose recommended for R vaccines (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>B).<fig id="Fig3" position="float" orientation="portrait"><label>Figure&#160;3</label><caption><p><bold><italic toggle="yes">wbdR</italic></bold><bold> tagging decreases the residual virulence of Rev1.</bold> BALB/C mice were inoculated with the indicated doses and CFU/spleen determined at post-infection weeks 1 and 5 (*<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="13567_2019_714_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec15"><title>Mice vaccinated with Rev1 <italic toggle="yes">wbdR</italic> constructs can be discriminated by ELISA</title><p id="Par21">We then analyzed by iELISA the sera of mice vaccinated with 10<sup>8</sup> CFU using first the S-LPS of Ba::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> as antigen. As expected, and no matter the vaccine, no serum from these mice showed ELISA reactivity one week post-infection (not shown). At week 5, whereas most sera of mice inoculated with the <italic toggle="yes">wbdR</italic> constructs showed some reactivity, sera of mice infected with Rev1 or <italic toggle="yes">B. melitensis</italic> did not react (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>A). Interestingly, the reverse picture was obtained in the iELISA with wild-type S-LPS as antigen: whereas mice infected with Rev1 or <italic toggle="yes">B. melitensis</italic> developed reacting antibodies, sera of mice inoculated with <italic toggle="yes">wbdR</italic> constructs displayed almost no reaction (Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>B) with small but consistently repeated (not shown) differences between Rev1::Tn7<italic toggle="yes">wbdR</italic> and Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC.</italic><fig id="Fig4" position="float" orientation="portrait"><label>Figure&#160;4</label><caption><p><bold>Mice vaccinated with Rev1</bold>
<bold><italic toggle="yes">wbdR</italic></bold><bold> constructs can be discriminated by iELISA.</bold> The sera of mice obtained 5&#160;weeks after inoculation with Rev1, Rev1::Tn7<italic toggle="yes">wbdR</italic> or Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> were analyzed by iELISA with N-acetyl-perosamine S-LPS (from a Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construct of <italic toggle="yes">B. abortus</italic> 2308) (<bold>A</bold>) or N-formyl-perosamine S-LPS (from <italic toggle="yes">B. melitensis</italic> 16&#160;M) (<bold>B</bold>). Sera from <italic toggle="yes">B. melitensis</italic> 16&#160;M-infected mice were included as a control. The serum dilutions used was 1:20 (<bold>A</bold>) and 1:40 (<bold>B</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="13567_2019_714_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec16"><title>Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> protects against <italic toggle="yes">B. ovis</italic> in the mouse model</title><p id="Par22">Based on the ELISA results and on its lack of reactivity with the anti-Formyl serum (Additional file <xref rid="MOESM4" ref-type="media">4</xref>), we chose Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> to study the efficacy of <italic toggle="yes">wbdR</italic> tagged vaccines against <italic toggle="yes">B. ovi</italic>s. As shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, this vaccine conferred protection at the two doses tested. However, only the 10<sup>8</sup> CFU/mouse dose (used for rough vaccines in the mouse model) conferred a&#160;protection similar to Rev1 at the standard dose (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Interestingly, even at this higher dose, the vaccine CFU remaining in the spleens was markedly lower than those of Rev1 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p><bold>Protection induced by Rev1::Tn7</bold><bold><italic toggle="yes">wbdR&#916;wbkC</italic></bold><bold> against</bold>
<bold><italic toggle="yes">B. ovis</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Vaccine (dose)</th><th align="left" colspan="2" rowspan="1">Mean&#8201;&#177;&#8201;SD of log<sub>10</sub> CFU in spleen of:</th><th align="left" rowspan="2" colspan="1">Units of protection</th></tr><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">B. ovis</italic></th><th align="left" colspan="1" rowspan="1">Vaccine</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Rev1 (10<sup>5</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.45&#8201;&#177;&#8201;1.35<sup>a</sup></td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.82&#8201;&#177;&#8201;0.99</td><td char="." align="char" colspan="1" rowspan="1">3.81</td></tr><tr><td align="left" colspan="1" rowspan="1">Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (10<sup>5</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">4.47&#8201;&#177;&#8201;1.40</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.69&#8201;&#177;&#8201;0.09<sup>c</sup></td><td char="." align="char" colspan="1" rowspan="1">1.79</td></tr><tr><td align="left" colspan="1" rowspan="1">Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> (10<sup>8</sup>)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.16&#8201;&#177;&#8201;0.95<sup>a, b</sup></td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.90&#8201;&#177;&#8201;0.53<sup>c</sup></td><td char="." align="char" colspan="1" rowspan="1">4.10</td></tr><tr><td align="left" colspan="1" rowspan="1">PBS (unvaccinated)</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">6.26&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.00</td></tr></tbody></table><table-wrap-foot><p>Statistical comparison (<italic toggle="yes">n</italic>&#8201;=&#8201;5) of mean log<sub>10</sub>
<italic toggle="yes">B. ovis</italic> CFU/spleen: <sup>a</sup><italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001 vs. PBS (unvaccinated), <sup>b</sup><italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05 vs. Rev1 and log<sub>10</sub> vaccine CFU/spleen <sup>c</sup>
<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01 vs. Rev1.</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec17"><title>Discussion</title><p id="Par23">The results presented in this work demonstrate that the O-PS of vaccine Rev1 can be antigenically tagged by genomic insertion of <italic toggle="yes">wbdR</italic>, the acetyltransferase gene involved in the synthesis of the O-PS repeating unit of <italic toggle="yes">E. coli</italic> O157:H7. Using the mouse model, we studied the protective capacity of <italic toggle="yes">wbdR</italic> tagged Rev1 against <italic toggle="yes">B. ovis</italic> and tested an ancillary ELISA DIVA test. In previous and preliminary experiments, we examined whether <italic toggle="yes">wbdR</italic> tagged brucellae (<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic>) could be used as antigen in a simple test similar to the Rose Bengal test for brucellosis. However, we observed that the modified brucellae had a marked tendency to autoagglutinate, a feature that is reminiscent of the autoagglutination typical of R brucellae [<xref ref-type="bibr" rid="CR16">16</xref>] and shows profound cell surface modifications. For this reason, we ruled out the agglutination test and applied an iELISA using the LPS purified from a <italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construct [<xref ref-type="bibr" rid="CR23">23</xref>] adjusted to minimize any cross-reactivity between acety-tagged and native O-PS. In this assay, we observed differences between the antibodies triggered by <italic toggle="yes">wbdR</italic> tagged vaccines when compared with those triggered by Rev1; whereas sera of mice vaccinated with Rev1::Tn7<italic toggle="yes">wbdR</italic> or Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> showed moderate reaction, sera corresponding to the Rev1 vaccinated mice did not react. Moreover, when the iELISA with wild-type S-LPS was used, contrary to the diagnostically interfering reaction showed by Rev1, the sera of mice inoculated with <italic toggle="yes">wbdR</italic> constructs displayed almost no reaction. In a previous work, we observed that the LPS of <italic toggle="yes">Brucella</italic> cross-reacting <italic toggle="yes">E. hermanii</italic> serotypes reacts strongly with sera from infected cattle [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] which are known to contain an overwhelming majority of antibodies of overlapping C specificities [<xref ref-type="bibr" rid="CR34">34</xref>]. The O-PS of these <italic toggle="yes">E. hermanii</italic> strains contains N-acetylated perosamine in an &#945; (1&#8211;3) and &#945; (1&#8211;2) linkage frequency and arrangement different from those in Rev1 (i.e. <italic toggle="yes">B. melitensis</italic> biovar 1) and cross-react with <italic toggle="yes">Brucella</italic> M monoclonal antibodies in gel immunoprecipitation [<xref ref-type="bibr" rid="CR33">33</xref>]. The O-PS in the <italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> constructs does not react in ELISA with C/Y-A&#8201;=&#8201;M or al C/Y-A&#8201;&gt;&#8201;M in ELISA [<xref ref-type="bibr" rid="CR23">23</xref>]. These data suggest epitopic differences that, in addition to differences in the intensity of the stimulus in an experimental infection in mice and a natural infection in cattle, in the subsequent different avidity of the antibodies and in the standardization of the ELISA, could account for these apparently contradictory results. Our results suggest that the use of <italic toggle="yes">wbdR</italic> tagged Rev1 and its ancillary ELISA might be a suitable strategy to solve the DIVA problem associated with the unmodified vaccine, but it is clear that experiments in sheep are necessary for a definite assessment.</p><p id="Par24">In keeping with previous studies in virulent brucellae [<xref ref-type="bibr" rid="CR23">23</xref>], the most profound modification was obtained in Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> and, accordingly, we tested its protective capacity in the mouse model. We observed that a 10<sup>8</sup> CFU/mouse dose was necessary to reach the protection levels obtained with Rev1 at 10<sup>5</sup> CFU/mouse. The recommended dose for brucellosis R vaccines is also 10<sup>8</sup> CFU/mouse [<xref ref-type="bibr" rid="CR35">35</xref>] and, like the autoagglutination commented above this suggests surface similarities between the Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> construct and R brucellae. The lack of O-PS in the latter increases the exposure of lipid A-core and Omp charged groups and it has been postulated that the OP-S acts as a negative modulator of unspecific interactions of these bacteria with host cells, thus favoring invasion for specific routes [<xref ref-type="bibr" rid="CR18">18</xref>]. On these bases, it can be hypothesized that either the N-acetyl-perosamine O-PS cannot replace the N-formyl-perosamine with regards to surface physicochemical properties and/or that the shorter O-PS of Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> constructs does not provide enough steric hindrance to the Omps and the lipid A-core section, as suggested by its sensitivity to the R/C phage. These surface changes may account for our observation that, when tested for the residual virulence (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>), we found that the CFU counts/spleen of Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> were lower than those of Rev1 even at a dose one thousand times higher, a result in agreement with the low numbers of CFU remaining in the spleens in the vaccination experiments (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Taken together, these results in mice suggest that Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> could be not only a DIVA vaccine but also a vaccine with reduced residual virulence in the host. Research is in progress to evaluate serological response and protective capacity against <italic toggle="yes">B. ovis</italic> of Rev1::Tn7<italic toggle="yes">wbdR</italic>&#916;<italic toggle="yes">wbkC</italic> in sheep.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2019_714_MOESM1_ESM.doc" position="float" orientation="portrait"><caption><p><bold>Additional file 1. Bacterial strains and plasmids.</bold>
</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2019_714_MOESM2_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 2. Primers.</bold>
</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2019_714_MOESM3_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 3. Differential characteristics of species of the genus </bold><bold><italic toggle="yes">Brucella</italic></bold><bold> and mutants.</bold>
</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13567_2019_714_MOESM4_ESM.docx" position="float" orientation="portrait"><caption><p><bold>Additional file 4. Insertion of </bold><bold><italic toggle="yes">wbdR</italic></bold><bold> into Rev1 genome modifies the epitopic structure of the vaccine.</bold>
</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Beatriz Arag&#243;n-Aranda and Mar&#237;a Jes&#250;s de Miguel contributed equally to this work</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13567-019-0714-3.</p></sec><ack><title>Acknowledgements</title><p>We thank A. Delgado-L&#243;pez for excellent technical assistance. We are also grateful to an anonymous reviewer for a helpful discussion of the results.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>RC-A, PM and IM conceived and coordinated the study. MI supervised the genomic studies. BA-A, MJdM, EM-G, AZ-R and MS-B performed experiments. RC-A, BA-A, PM, and IM wrote the manuscript. All authors analyzed the results and approved the final version of the manuscript. RC-A, AZ-R, MI and IM are inventors of patent EP15201717.4 covering potential uses of <italic toggle="yes">wbdR</italic> constructs. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research was supported by the Institute for Tropical Health funders (Obra Social la CAIXA-LCF/PR/PR13/11080005- and Fundaci&#243;n Caja Navarra, Fundaci&#243;n Mar&#237;a Francisca de Roviralta, Ubesol and Inversiones Garcilaso de la Vega S.L.) and grants MINECO (AGL2014-58795-C4-1-R). B.A.A. is the recipient of the Ph.D. Fellowship BES-2015-075609 funded by the MINECO.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par25">Studies in mice were done&#160;in accordance with the current European (directive 86/609/EEC) and Spanish (RD 53/2013) legislations, supervised by both Ethical Committee for Animal Experimentation of CITA and Animal Welfare Committee of the University of Navarra and authorised by Arag&#243;n (reports No. 2014-20 and 2014-21) and Navarra (CEEA 045/12) Governments.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par26">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDermott</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Grace</surname><given-names>D</given-names></name><name name-style="western"><surname>Zinsstag</surname><given-names>J</given-names></name></person-group><article-title>Economics of brucellosis impact and control in low-income countries</article-title><source>Rev Sci Tech</source><year>2013</year><volume>32</volume><fpage>249</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.20506/rst.32.1.2197</pub-id><pub-id pub-id-type="pmid">23837382</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>Retrospective and prospective perspectives on zoonotic brucellosis</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00213</pub-id><pub-id pub-id-type="pmid">24860561</pub-id><pub-id pub-id-type="pmcid">PMC4026726</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Nielsen</surname><given-names>KH</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>JR</given-names></name></person-group><article-title><italic toggle="yes">Brucella ovis</italic></article-title><source>In: Animal brucellosis</source><year>1990</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>352</fpage><lpage>378</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Molina-Flores</surname><given-names>B</given-names></name></person-group><article-title>Control and eradication of <italic toggle="yes">Brucella melitensis</italic> infection in sheep and goats</article-title><source>Vet Clin North Am Food Anim Pract</source><year>2011</year><volume>27</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.cvfa.2010.10.003</pub-id><pub-id pub-id-type="pmid">21215893</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish A, Roushan MRH, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G, International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina</collab></person-group><article-title>Perspectives for the treatment of brucellosis in the 21st century: rhe Ioannina recommendations</article-title><source>PLoS Med</source><year>2007</year><volume>4</volume><fpage>e317</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0040317</pub-id><pub-id pub-id-type="pmid">18162038</pub-id><pub-id pub-id-type="pmcid">PMC2222927</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">OIE (2018) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. World Organ Anim Heal. Brucellosis pp:355&#8211;398</mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis</article-title><source>Clin Diagn Lab Immunol</source><year>1999</year><volume>6</volume><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">10066666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/cdli.6.2.269-272.1999</pub-id><pub-id pub-id-type="pmcid">PMC95699</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Jim&#233;nez de Bag&#252;&#233;s</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Alonso-Urmeneta</surname><given-names>B</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of whole cell and subcellular vaccines against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vet Immunol Immunopathol</source><year>1993</year><volume>37</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/0165-2427(93)90198-D</pub-id><pub-id pub-id-type="pmid">8236802</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da Costa</surname><given-names>Martins R</given-names></name><name name-style="western"><surname>Irache</surname><given-names>JM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name></person-group><article-title>Evaluation of particulate acellular vaccines against <italic toggle="yes">Brucella ovis</italic> infection in rams</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>3038</fpage><lpage>3046</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.10.073</pub-id><pub-id pub-id-type="pmid">19887131</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soler-Llor&#233;ns</surname><given-names>P</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names>A</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>San Rom&#225;n</surname><given-names>B</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name></person-group><article-title>Mutants in the lipopolysaccharide of <italic toggle="yes">Brucella ovis</italic> are attenuated and protect against <italic toggle="yes">B ovis</italic> infection in mice</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>72</fpage><pub-id pub-id-type="pmid">25029920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13567-014-0072-0</pub-id><pub-id pub-id-type="pmcid">PMC4107470</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>APC</given-names></name><name name-style="western"><surname>Mac&#234;do</surname><given-names>AA</given-names></name><name name-style="western"><surname>Silva</surname><given-names>TMA</given-names></name><name name-style="western"><surname>Ximenes</surname><given-names>LCA</given-names></name><name name-style="western"><surname>Brand&#227;o</surname><given-names>HM</given-names></name><name name-style="western"><surname>Paix&#227;o</surname><given-names>TA</given-names></name><name name-style="western"><surname>Santos</surname><given-names>L</given-names></name></person-group><article-title>Protection provided by an encapsulated live attenuated &#916; abcBA strain of <italic toggle="yes">Brucella ovis</italic> against experimental challenge in a murine model</article-title><source>Clin Vaccine Immunol</source><year>2015</year><volume>22</volume><fpage>789</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1128/CVI.00191-15</pub-id><pub-id pub-id-type="pmid">25947146</pub-id><pub-id pub-id-type="pmcid">PMC4478529</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>APC</given-names></name><name name-style="western"><surname>Mac&#234;do</surname><given-names>AA</given-names></name><name name-style="western"><surname>Costa</surname><given-names>LF</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>CE</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>LNN</given-names></name><name name-style="western"><surname>Farias</surname><given-names>JRD</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>PPR</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>GC</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>KWJ</given-names></name><name name-style="western"><surname>Maia</surname><given-names>ARF</given-names></name><name name-style="western"><surname>Neves</surname><given-names>GG</given-names></name><name name-style="western"><surname>Rom&#227;o</surname><given-names>EL</given-names></name><name name-style="western"><surname>Silva</surname><given-names>TMA</given-names></name><name name-style="western"><surname>Mol</surname><given-names>JPS</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>RM</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>MSS</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>EF</given-names></name><name name-style="western"><surname>Martins-Filho</surname><given-names>OA</given-names></name><name name-style="western"><surname>Brand&#227;o</surname><given-names>HM</given-names></name><name name-style="western"><surname>Paix&#227;o</surname><given-names>TA</given-names></name><name name-style="western"><surname>Santoset</surname><given-names>RL</given-names></name></person-group><article-title>Encapsulated <italic toggle="yes">Brucella ovis</italic> lacking a putative ATP-binding cassette transporter (&#916;abcBA) protects against wild type <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0136865</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0136865</pub-id><pub-id pub-id-type="pmid">26317399</pub-id><pub-id pub-id-type="pmcid">PMC4552948</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Etayo</surname><given-names>L</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Khames</surname><given-names>M</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name></person-group><article-title>The CO2-dependence of <italic toggle="yes">Brucella ovis</italic> and <italic toggle="yes">Brucella abortus</italic> biovars is caused by defective carbonic anhydrases</article-title><source>Vet Res</source><year>2018</year><volume>49</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s13567-018-0583-1</pub-id><pub-id pub-id-type="pmid">30185220</pub-id><pub-id pub-id-type="pmcid">PMC6126018</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrio</surname><given-names>MB</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name></person-group><article-title>Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against <italic toggle="yes">Brucella melitensis</italic> infection of sheep</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>1741</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.025</pub-id><pub-id pub-id-type="pmid">19186196</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gusi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bertu</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Jes&#250;s de Miguel</surname><given-names>M</given-names></name><name name-style="western"><surname>Dieste-P&#233;rez</surname><given-names>L</given-names></name><name name-style="western"><surname>Smits</surname><given-names>HL</given-names></name><name name-style="western"><surname>Ocholi</surname><given-names>RA</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name></person-group><article-title>Comparative performance of lateral flow immunochromatography, iELISA and Rose Bengal tests for the diagnosis of cattle, sheep, goat and swine brucellosis</article-title><source>PLoS Negl Trop Dis</source><year>2019</year><volume>13</volume><fpage>e0007509</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0007509</pub-id><pub-id pub-id-type="pmid">31216271</pub-id><pub-id pub-id-type="pmcid">PMC6602290</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ducrotoy</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>A review of the basis of the immunological diagnosis of ruminant brucellosis</article-title><source>Vet Immunol Immunopathol</source><year>2016</year><volume>171</volume><fpage>81</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2016.02.002</pub-id><pub-id pub-id-type="pmid">26964721</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfroid</surname><given-names>F</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Taminiau</surname><given-names>B</given-names></name><name name-style="western"><surname>Danese</surname><given-names>I</given-names></name><name name-style="western"><surname>Tibor</surname><given-names>A</given-names></name><name name-style="western"><surname>de Bolle</surname><given-names>X</given-names></name><name name-style="western"><surname>Mertens</surname><given-names>P</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name></person-group><article-title>Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of <italic toggle="yes">Brucella melitensis</italic> 16&#160;M (<italic toggle="yes">wbk</italic>)</article-title><source>Res Microbiol</source><year>2000</year><volume>151</volume><fpage>655</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/S0923-2508(00)90130-X</pub-id><pub-id pub-id-type="pmid">11081580</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T</given-names></name><name name-style="western"><surname>Arce-gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>RM</given-names></name><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>A</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2760</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002760</pub-id><pub-id pub-id-type="pmid">18648644</pub-id><pub-id pub-id-type="pmcid">PMC2453230</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Sancho</surname><given-names>M</given-names></name><name name-style="western"><surname>Adone</surname><given-names>R</given-names></name><name name-style="western"><surname>Garc&#237;a-Seco</surname><given-names>T</given-names></name><name name-style="western"><surname>Tarantino</surname><given-names>M</given-names></name><name name-style="western"><surname>Diez-Guerrier</surname><given-names>A</given-names></name><name name-style="western"><surname>Drumo</surname><given-names>R</given-names></name><name name-style="western"><surname>Francia</surname><given-names>M</given-names></name><name name-style="western"><surname>Dom&#237;nguez</surname><given-names>L</given-names></name><name name-style="western"><surname>Pasquali</surname><given-names>P</given-names></name><name name-style="western"><surname>&#193;lvarez</surname><given-names>J</given-names></name></person-group><article-title>Evaluation of the immunogenicity and safety of <italic toggle="yes">Brucella melitensis</italic> B115 vaccination in pregnant sheep</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>1877</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.01.070</pub-id><pub-id pub-id-type="pmid">24508034</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Laroucau</surname><given-names>K</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Efficacy of bp26 and bp26/omp31 B. melitensis Rev. 1 deletion mutants against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vaccine.</source><year>2009</year><volume>27</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.10.065</pub-id><pub-id pub-id-type="pmid">19007836</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Marin</surname><given-names>CM</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>D</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>R</given-names></name><name name-style="western"><surname>Mainar-Jaime</surname><given-names>RC</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to <italic toggle="yes">Yersinia enterocolitica</italic> O:9</article-title><source>Clin Vaccine Immunol</source><year>2005</year><volume>12</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1128/CDLI.12.1.141-151.2005</pub-id><pub-id pub-id-type="pmcid">PMC540215</pub-id><pub-id pub-id-type="pmid">15642999</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names>A</given-names></name><name name-style="western"><surname>San-Rom&#225;n</surname><given-names>B</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>M-J</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P-M</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name></person-group><article-title>GFP tagging of <italic toggle="yes">Brucella melitensis</italic> Rev1 allows the identification of vaccinated sheep</article-title><source>Transbound Emerg Dis</source><year>2019</year><volume>66</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1111/tbed.13053</pub-id><pub-id pub-id-type="pmid">30375177</pub-id><pub-id pub-id-type="pmcid">PMC7379934</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez-G&#243;mez</surname><given-names>E</given-names></name><name name-style="western"><surname>St&#229;hle</surname><given-names>J</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A</given-names></name><name name-style="western"><surname>Zaccheus</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name></person-group><article-title>genomic insertion of a heterologous acetyltransferase generates a new lipopolysaccharide antigenic structure in <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella melitensis</italic></article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1092</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01092</pub-id><pub-id pub-id-type="pmid">29887851</pub-id><pub-id pub-id-type="pmcid">PMC5981137</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allard</surname><given-names>N</given-names></name><name name-style="western"><surname>Garneau</surname><given-names>D</given-names></name><name name-style="western"><surname>Poulin-Laprade</surname><given-names>D</given-names></name><name name-style="western"><surname>Burrus</surname><given-names>V</given-names></name><name name-style="western"><surname>Brzezinski</surname><given-names>R</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name></person-group><article-title>A diaminopimelic acid auxotrophic <italic toggle="yes">Escherichia coli</italic> donor provides improved counterselection following intergeneric conjugation with actinomycetes</article-title><source>Can J Microbiol</source><year>2015</year><volume>61</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1139/cjm-2015-0041</pub-id><pub-id pub-id-type="pmid">26166710</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>K-H</given-names></name><name name-style="western"><surname>Gaynor</surname><given-names>JB</given-names></name><name name-style="western"><surname>White</surname><given-names>KG</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>C</given-names></name><name name-style="western"><surname>Bosio</surname><given-names>CM</given-names></name><name name-style="western"><surname>Karkhoff-Schweizer</surname><given-names>RR</given-names></name><name name-style="western"><surname>Schweizer</surname><given-names>HP</given-names></name></person-group><article-title>A Tn7-based broad-range bacterial cloning and expression system</article-title><source>Nat Methods</source><year>2005</year><volume>2</volume><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1038/nmeth765</pub-id><pub-id pub-id-type="pmid">15908923</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Llobet</surname><given-names>E</given-names></name><name name-style="western"><surname>March</surname><given-names>C</given-names></name><name name-style="western"><surname>Gimenez</surname><given-names>P</given-names></name><name name-style="western"><surname>Bengoechea</surname><given-names>JA</given-names></name></person-group><article-title><italic toggle="yes">Klebsiella pneumoniae</italic> OmpA confers resistance to antimicrobial peptides</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1128/AAC.00657-08</pub-id><pub-id pub-id-type="pmid">19015361</pub-id><pub-id pub-id-type="pmcid">PMC2612193</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name><name name-style="western"><surname>Jones</surname><given-names>LM</given-names></name><name name-style="western"><surname>Angus</surname><given-names>RD</given-names></name><name name-style="western"><surname>Verger</surname><given-names>J-M</given-names></name></person-group><source>Techniques for the brucellosis laboratory</source><year>1988</year><publisher-loc>Paris</publisher-loc><publisher-name>INRA</publisher-name></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubray</surname><given-names>G</given-names></name><name name-style="western"><surname>Limet</surname><given-names>J</given-names></name></person-group><article-title>Evidence of heterogeneity of lipopolysaccharides among <italic toggle="yes">Brucella</italic> biovars in relation to A and M specificities</article-title><source>Ann Inst Pasteur Microbiol</source><year>1987</year><volume>138</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/0769-2609(87)90051-2</pub-id><pub-id pub-id-type="pmid">3300718</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garin Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name><name name-style="western"><surname>Dubray</surname><given-names>G</given-names></name><name name-style="western"><surname>Limet</surname><given-names>JN</given-names></name></person-group><article-title>Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting analysis of smooth-lipopolysaccharide heterogeneity among <italic toggle="yes">Brucella</italic> biovars related to A and M specificities</article-title><source>J Clin Microbiol</source><year>1990</year><volume>28</volume><fpage>2169</fpage><lpage>2174</lpage><pub-id pub-id-type="pmid">2229339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.28.10.2169-2174.1990</pub-id><pub-id pub-id-type="pmcid">PMC268140</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>C-M</given-names></name><name name-style="western"><surname>Frasch</surname><given-names>CE</given-names></name></person-group><article-title>A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels</article-title><source>Anal Biochem</source><year>1982</year><volume>119</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(82)90673-X</pub-id><pub-id pub-id-type="pmid">6176137</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Garc&#237;a-Yoldi</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Guzm&#225;n-Verri</surname><given-names>C</given-names></name><name name-style="western"><surname>Albert</surname><given-names>D</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>New Bruce-ladder multiplex PCR assay for the biovar typing of <italic toggle="yes">Brucella suis</italic> and the discrimination of <italic toggle="yes">Brucella suis</italic> and <italic toggle="yes">Brucella canis</italic></article-title><source>Vet Microbiol</source><year>2011</year><volume>154</volume><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2011.06.035</pub-id><pub-id pub-id-type="pmid">21782356</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Manterola</surname><given-names>L</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name></person-group><article-title>Increases of efficacy as vaccine against <italic toggle="yes">Brucella abortus</italic> infection in mice by simultaneous inoculation with avirulent smooth <italic toggle="yes">bvrS/bvrR</italic> and rough <italic toggle="yes">wbkA</italic> mutants</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>2910</fpage><lpage>2916</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.12.038</pub-id><pub-id pub-id-type="pmid">16439039</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>MB</given-names></name><name name-style="western"><surname>Bundle</surname><given-names>DR</given-names></name></person-group><article-title>Antigenic relationships of the lipopolysaccharides of <italic toggle="yes">Escherichia hermannii</italic> strains with those of <italic toggle="yes">Escherichia coli</italic> O157:H7, <italic toggle="yes">Brucella melitensis</italic>, and <italic toggle="yes">Brucella abortus</italic></article-title><source>Infect Immun</source><year>1990</year><volume>58</volume><fpage>1391</fpage><lpage>1395</lpage><pub-id pub-id-type="pmid">1691146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.58.5.1391-1395.1990</pub-id><pub-id pub-id-type="pmcid">PMC258637</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso-Urmeneta</surname><given-names>B</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Arag&#243;n</surname><given-names>V</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle</article-title><source>Clin Diagn Lab Imunol</source><year>1998</year><volume>5</volume><fpage>749</fpage><lpage>754</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/cdli.5.6.749-754.1998</pub-id><pub-id pub-id-type="pmcid">PMC96196</pub-id><pub-id pub-id-type="pmid">9801329</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status</article-title><source>Vet Res</source><year>2004</year><volume>35</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1051/vetres:2003037</pub-id><pub-id pub-id-type="pmid">15099501</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>